Abstract
Introduction

70
Current pneumococcal conjugate vaccines have significantly reduced invasive 71 disease caused by the included Streptococcus pneumoniae (pneumococcal) serotypes.
72
However, the currently licensed vaccines, PCV-10 and PCV-13, target only 10 or 13 of 
268
Additionally, carriage of PspA variants was not found to vary by age. 
344
However, these underlying population dynamics require further exploration.
345
In prior studies, anti-PspA titers in children reflected the PspA family to which 346 they had been exposed (14), while adults often possessed high titers to both major 347 families. Among participants of this study, family 2 PspA variants were found in only 348 27% of carriage isolates and mean anti-PspA family 2 variant titers were consistently 349 lower among each age group. However, we found that anti-PspA titers were not 
358
Previously estimated to be present in ~30% of pneumococci (36), pilus was present in 359 only 11% of our studied strains. We found that while anti-pilus antibody titers were 360 significantly higher among adults compared with children, there was no difference in the 361 proportion of carried strains that were piliated between these age groups. Furthermore, 
369
While for the majority of protein antigen variants we failed to find any variant-370 specific protective effect against carriage, it should be noted that immunity generated by 
